Isoxepac CAS 55453-87-7 Puritas >99.0% (HPLC) Olopatadinum Hydrochloridum medium Factory
Ducens Supplier de Olopatadine Hydrochloride intermedia
Olopatadinum hydrochloridum CAS 140462-76-6
Isoxepac CAS 55453-87-7
3-(Dimethylamino)propyl] triphenylphosphonium Bromide Hydrobromide CAS 27710-82-3
Please Contact: alvin@ruifuchem.com
| Nomen chemicum | Isoxepac |
| Synonyma | 6,11-Dihydro-11-Oxodibenzo[b,e]oxepin-2-Acidum aceticum;6H-11-Oxodibenzo[b,e]oxepin-2-acetic acidum;HP 549 |
| immunditia | Olopatadine immunditia 3;Olopatadine USP Related Compound C;Olapatadine EP Impuritas C |
| CAS Number | 55453-87-7 |
| CATTUS Number | RF2697 |
| Stock Status | In Stock, Productio Capacity 30 Tons per Month |
| Formulae hypotheticae | C16H12O4 |
| M. Pondus | 268.27 |
| Liquescens punctum | 137.0~142.0℃ |
| Density | 1.39 g/cm3 |
| Solubilitas | Solutum in Methanol |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Lux-Yellow ad Off-White Crystalline pulveris |
| Lepidium sativum | HPC / UV |
| Puritas / Analysis Methodus | >99.0% (HPLC) |
| Liquescens punctum | 137.0~142.0℃ |
| Aqua (auctore Karl Fischer) | <0.50% |
| Damnum in Siccatio | <0.50% |
| Metalla gravis | <20ppm |
| Totalis immunditias | <1.00% |
| Infrared Imaginis | Conformat ut Structure |
| Proton NMR Spectrum | Conformat ut Structure |
| Test Standard | Enterprise Standard |
| Consuetudinem | Intermedia / Impuritas Hydrochloridis Olopatadini (CAS: 140462-76-6) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Isoxepac (CAS: 55453-87-7) media est Hydrochloridi Olopatadini (CAS: 140462-76-6).Olopatadinum hydrochloridum est malum cellae histaminis inhibitoris emissio et receptaculum selectivum H1 adversarium.Olopatadinum tabulae hydrochloridis / capsulae allergicae sunt pro rhinitis, urticaria, pruritus (eczema, dermatitis, pruritus, psoriasis vulgaris, erythema multiforme exudativa).Olopatadine hydrochloridis oculi guttae tractandae sunt salubria allergici conjunctivitis.Olopatadinum hydrochloridum medicamentum anti-allergicum est.Effectus duplices habet inhibendi emissione histaminis et selective repugnantis receptoribus HI, nec habet systema nervosum centrale inhibitionis et cardiaci toxici lateris effectus communes cum III receptore contra pharmaca antiallergica.Medicamentum histaminum e cellulis malii non solum inhibere, sed etiam receptores selectiores H1 infestare, neque in receptoribus adrenergicis, dopamine receptoribus, et M1 et M2 receptoribus nihil valet.Inter eos, effectus laterum systematis nervosi centralis pauci sunt, est nova generatio medicamentorum antiallergicarum electionis.
